272 related articles for article (PubMed ID: 10397533)
1. Joint effects of HIV-1 RNA levels and CD4 lymphocyte cells on the risk of specific opportunistic infections.
Williams PL; Currier JS; Swindells S
AIDS; 1999 Jun; 13(9):1035-44. PubMed ID: 10397533
[TBL] [Abstract][Full Text] [Related]
2. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.
Jones JL; Hanson DL; Dworkin MS; Alderton DL; Fleming PL; Kaplan JE; Ward J
MMWR CDC Surveill Summ; 1999 Apr; 48(2):1-22. PubMed ID: 12412613
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of plasma HIV RNA in the natural history of Pneumocystis carinii pneumonia, cytomegalovirus and Mycobacterium avium complex. Multicenter AIDS Cohort Study.
Lyles RH; Chu C; Mellors JW; Margolick JB; Detels R; Giorgi JV; Al-Shboul Q; Phair JP
AIDS; 1999 Feb; 13(3):341-9. PubMed ID: 10199224
[TBL] [Abstract][Full Text] [Related]
4. Patterns of opportunistic infections in patients with HIV infection.
Finkelstein DM; Williams PL; Molenberghs G; Feinberg J; Powderly WG; Kahn J; Dolin R; Cotton D
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 May; 12(1):38-45. PubMed ID: 8624759
[TBL] [Abstract][Full Text] [Related]
5. Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team.
Currier JS; Williams PL; Koletar SL; Cohn SE; Murphy RL; Heald AE; Hafner R; Bassily EL; Lederman HM; Knirsch C; Benson CA; Valdez H; Aberg JA; McCutchan JA
Ann Intern Med; 2000 Oct; 133(7):493-503. PubMed ID: 11015162
[TBL] [Abstract][Full Text] [Related]
6. OI prophylaxis in antiretroviral responders: stay the course or bite the bullet?
Currier JS
AIDS Clin Care; 1998 Oct; 10(10):73-5, 79-80. PubMed ID: 11365859
[TBL] [Abstract][Full Text] [Related]
7. Stopping preventive treatments.
Fornataro K; Jefferys R
Body Posit; 1999 Jul; 12(7):9-10. PubMed ID: 11367080
[TBL] [Abstract][Full Text] [Related]
8. Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?
; Mocroft A; Reiss P; Kirk O; Mussini C; Girardi E; Morlat P; Stephan C; De Wit S; Doerholt K; Ghosn J; Bucher HC; Lundgren JD; Chene G; Miro JM; Furrer H
Clin Infect Dis; 2010 Sep; 51(5):611-9. PubMed ID: 20645862
[TBL] [Abstract][Full Text] [Related]
9. Is primary mycobacterium avium complex prophylaxis necessary in patients with CD4 <50 cells/μL who are virologically suppressed on cART?
Yangco BG; Buchacz K; Baker R; Palella FJ; Armon C; Brooks JT;
AIDS Patient Care STDS; 2014 Jun; 28(6):280-3. PubMed ID: 24833016
[TBL] [Abstract][Full Text] [Related]
10. Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy.
Salmon-Céron D; Mazeron MC; Chaput S; Boukli N; Senechal B; Houhou N; Katlama C; Matheron S; Fillet AM; Gozlan J; Leport C; Jeantils V; Freymuth F; Costagliola D
AIDS; 2000 May; 14(8):1041-9. PubMed ID: 10853987
[TBL] [Abstract][Full Text] [Related]
11. The cost-effectiveness of preventing AIDS-related opportunistic infections.
Freedberg KA; Scharfstein JA; Seage GR; Losina E; Weinstein MC; Craven DE; Paltiel AD
JAMA; 1998 Jan; 279(2):130-6. PubMed ID: 9440663
[TBL] [Abstract][Full Text] [Related]
12. Opportunistic infections update.
Proj Inf Perspect; 1999 Apr; (27):19-20. PubMed ID: 11366735
[TBL] [Abstract][Full Text] [Related]
13. Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group.
Weverling GJ; Mocroft A; Ledergerber B; Kirk O; Gonzáles-Lahoz J; d'Arminio Monforte A; Proenca R; Phillips AN; Lundgren JD; Reiss P
Lancet; 1999 Apr; 353(9161):1293-8. PubMed ID: 10218526
[TBL] [Abstract][Full Text] [Related]
14. Opportunistic infections occurring during highly active antiretroviral treatment.
Michelet C; Arvieux C; François C; Besnier JM; Rogez JP; Breux JP; Souala F; Allavena C; Raffi F; Garre M; Cartier F
AIDS; 1998 Oct; 12(14):1815-22. PubMed ID: 9792382
[TBL] [Abstract][Full Text] [Related]
15. Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy.
Dankner WM; Lindsey JC; Levin MJ;
Pediatr Infect Dis J; 2001 Jan; 20(1):40-8. PubMed ID: 11176565
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98.
Lopez Bernaldo de Quiros JC; Miro JM; Peña JM; Podzamczer D; Alberdi JC; Martínez E; Cosin J; Claramonte X; Gonzalez J; Domingo P; Casado JL; Ribera E;
N Engl J Med; 2001 Jan; 344(3):159-67. PubMed ID: 11172138
[TBL] [Abstract][Full Text] [Related]
17. Pneumocystis jiroveci pneumonia prophylaxis is not required with a CD4+ T-cell count < 200 cells/microl when viral replication is suppressed.
D'Egidio GE; Kravcik S; Cooper CL; Cameron DW; Fergusson DA; Angel JB
AIDS; 2007 Aug; 21(13):1711-5. PubMed ID: 17690568
[TBL] [Abstract][Full Text] [Related]
18. No news is good news: opportunistic infections.
Chaisson RE; Bishai W
Hopkins HIV Rep; 1998 Nov; 10(6):2, 11. PubMed ID: 11366129
[TBL] [Abstract][Full Text] [Related]
19. Adherence to guidelines for antiretroviral therapy and for preventing opportunistic infections in HIV-infected adults and adolescents in Ryan White-funded facilities in the United States.
Kaplan JE; Parham DL; Soto-Torres L; van Dyck K; Greaves JA; Rauch K; Ellis B; Amandus HE
J Acquir Immune Defic Syndr; 1999 Jul; 21(3):228-35. PubMed ID: 10421247
[TBL] [Abstract][Full Text] [Related]
20. Relation between CD4 cell counts and HIV RNA levels at onset of opportunistic infections.
Brambilla AM; Castagna A; Nocita B; Hasson H; Boeri E; Veglia F; Lazzarin A
J Acquir Immune Defic Syndr; 2001 May; 27(1):44-8. PubMed ID: 11404519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
